Geographic variation and racial disparities in adoption of newer glucose-lowering drugs with cardiovascular benefits among US Medicare beneficiaries with type 2 diabetes.

导出 OA

翻译打印收藏纠错

第一作者： Wei-Han,Chen

第一单位： Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville, Florida, United States of America.

作者： Wei-Han,Chen ^[1] ; Yujia,Li ^[1] ; Lanting,Yang ^[2] ; John M,Allen ^[3] ; Hui,Shao ^[4] ; William T,Donahoo ^[5] ; Lori,Billelo ^[6] ; Xia,Hu ^[7] ; Elizabeth A,Shenkman ^[8] ; Jiang,Bian ^[8] ; Steven M,Smith ^[9] ; Jingchuan,Guo ^[9]

作者单位： Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville, Florida, United States of America. ^[1] Department of Pharmacy and Therapeutics, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America. ^[2] Department of Pharmacotherapy & Translational Research, College of Pharmacy, University of Florida, Gainesville, Florida, United States of America.;Center for Drug Evaluation and Safety (CoDES), College of Pharmacy, University of Florida, Gainesville, Florida, United States of America. ^[3] Hubert Department of Global Health, Rollin School of Public Health, Emory University, Atlanta, Georgia, United States of America.;Department of Family and Preventive Medicine, School of Medicine, Emory University, Atlanta, Georgia, United States of America. ^[4] Center for Drug Evaluation and Safety (CoDES), College of Pharmacy, University of Florida, Gainesville, Florida, United States of America.;Division of Endocrinology, Diabetes & Metabolism, Department of Medicine, College of Medicine, University of Florida, Gainesville, Florida, United States of America. ^[5] Office of Research Affairs, University of Florida College of Medicine-Jacksonville, Jacksonville, Florida, United States of America. ^[6] Department of Computer Science, Rice University, Houston, Texas, United States of America. ^[7] Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, Florida, United States of America. ^[8] Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville, Florida, United States of America.;Center for Drug Evaluation and Safety (CoDES), College of Pharmacy, University of Florida, Gainesville, Florida, United States of America. ^[9]